首页> 外国专利> New light, oxygen, voltage domains, and proteins containing them, useful as fluorescent markers, e.g. in gene therapy, cloning and cell sorting, are altered to prevent covalent bonding to flavine mononucleotide

New light, oxygen, voltage domains, and proteins containing them, useful as fluorescent markers, e.g. in gene therapy, cloning and cell sorting, are altered to prevent covalent bonding to flavine mononucleotide

机译:新的光,氧,电压域和包含它们的蛋白质,可用作荧光标记,例如在基因治疗中,克隆和细胞分选被改变以防止与黄素单核苷酸共价键合

摘要

LOV (= light, oxygen, voltage) domains (A) in which at least one Cys is replaced by another amino acid (aa) that does not bind covalently to flavine mononucleotide are new. Independent claims are included for the following: (1) LOV-proteins (B) that include (A); (2) nucleic acid (NA) that encodes (A) or (B); (3) vector containing DNA Seq. (3), (4) or (5); (4) chromosome that contains at least one of Seq. (3)-(11) or (13); (5) genetically modified cells that contain a chromosome of (4) or vector of (3); (6) method for producing (A) or (B) by exchanging a Cys with an aa that can not form a covalent bond to FMN; (7) a protein (P) characterized by the sequence Gly-X-Asn-Cys-Arg-Phe-Leu-Gln (where X = any aa other than Cys) and having Cys at position 4 replaced by a different aa; and (8) FMN-carrying photoreceptor (PR) in which the FMN is not covalently bonded.
机译:新的LOV(=光,氧,电压)域(A),其中至少一个Cys被另一种不与黄素单核苷酸共价结合的氨基酸(aa)取代。包括以下方面的独立权利要求:(1)LOV蛋白(B),包括(A); (2)编码(A)或(B)的核酸(NA); (3)含有DNA Seq的载体。 (3),(4)或(5); (4)含有至少一个Seq.1的染色体。 (3)-(11)或(13); (5)含有(4)的染色体或(3)的载体的转基因细胞; (6)通过将Cys与不能与FMN形成共价键的aa交换来制备(A)或(B)的方法; (7)一种蛋白质(P),其特征在于序列Gly-X-Asn-Cys-Arg-Phe-Leu-Gln(其中X =除Cys以外的任何氨基酸),并且在4位的Cys被不同的aa取代。 (8)FMN未共价键合的携带FMN的感光体(PR)。

著录项

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号